a Johnson & Johnson (J&J) Said on Tuesday that he is talking to the government India to study ways to speed up the delivery of your vaccine against COVID-19 Single dose in the country.
Earlier this Tuesday, the Economic Times reported that the company would no longer conduct local trials of its vaccine in view of India’s decision to skip clinical trials of India’s linkage. Vaccines Approved by regulatory agencies of other countries.
J&J did not specify in its remarks whether the test should be ruled out.
In April, the headquarters of the company . was in America said that it is seeking approval to conduct clinical linkage trials of its Janssen subsidiary’s COVID-19 vaccine candidate in India.
In late May, however, the country rejected local testing of “well-established” vaccines manufactured in other countries.
More than 41 million doses of the vaccine were administered across India in the past week alone, when experts say widespread vaccination is one of the best tools to avert the devastation the country experienced during the second wave of the pandemic.
